• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产后重组凝血因子VIII治疗的甲型血友病携带者孕妇发生血栓形成

Thrombosis in a pregnant hemophilia A carrier after intrapartum recombinant factor VIII.

作者信息

Russell Zoi, Riconda Dan, Pollack Lynda, O'Leary Timothy D, Carlan S J

机构信息

Department of Obstetrics and Gynecology, Arnold Palmer Hospital for Children and Women, Orlando Regional Healthcare, Orlando, Florida, USA.

出版信息

Obstet Gynecol. 2005 Apr;105(4):875-6. doi: 10.1097/01.AOG.0000141648.05771.24.

DOI:10.1097/01.AOG.0000141648.05771.24
PMID:15802420
Abstract

BACKGROUND

Symptomatic hemophilia A is a rare disorder in females. Pregnancy and delivery in such women can be life threatening. Obstetric management is challenging and requires a multidisciplinary approach to ensure a good outcome.

CASE

A woman with hemophilia A delivered by cesarean developed a deep vein thrombosis 10 days postpartum after recombinant factor VIII administration.

CONCLUSION

Hemophilia A due to skewed X-inactivation is a rare cause of peripartum bleeding. Recombinant factor VIII administration can prevent hemorrhage during and after cesarean delivery but may be associated with development of deep vein thrombosis.

摘要

背景

有症状的甲型血友病在女性中是一种罕见疾病。此类女性的妊娠和分娩可能危及生命。产科管理具有挑战性,需要多学科方法以确保良好结局。

病例

一名甲型血友病女性剖宫产分娩,产后10天在给予重组凝血因子VIII后发生深静脉血栓形成。

结论

由于X染色体失活偏倚导致的甲型血友病是围产期出血的罕见原因。给予重组凝血因子VIII可预防剖宫产期间及术后出血,但可能与深静脉血栓形成有关。

相似文献

1
Thrombosis in a pregnant hemophilia A carrier after intrapartum recombinant factor VIII.产后重组凝血因子VIII治疗的甲型血友病携带者孕妇发生血栓形成
Obstet Gynecol. 2005 Apr;105(4):875-6. doi: 10.1097/01.AOG.0000141648.05771.24.
2
Acquired hemophilia secondary to factor VIII inhibitors after pregnancy.妊娠后继发于VIII因子抑制剂的获得性血友病
Ann Med Interne (Paris). 1998 Sep;149(5):300-2.
3
[Macrohaematuria post-partum: an unusual case of acquired haemophilia after pregnancy].产后肉眼血尿:一例妊娠后获得性血友病的罕见病例
G Ital Nefrol. 2002 Mar-Apr;19(2):204-8.
4
[Management of cesarean section under replacement therapy with factor VIII concentrates in a pregnant case with congenital combined deficiency of factor V and factor VIII].
Rinsho Ketsueki. 1991 Sep;32(9):981-5.
5
Heterozygous hemophilia developed during pregnancy.
J Obstet Gynaecol Res. 2005 Feb;31(1):50-1. doi: 10.1111/j.1447-0756.2005.00239.x.
6
New observations in postpartum ovarian vein thrombosis: experience of single center.产后卵巢静脉血栓形成的新观察:单中心经验
Blood Coagul Fibrinolysis. 2010 Jan;21(1):16-9. doi: 10.1097/MBC.0b013e32832f2ada.
7
[Postpartum hemophilia A with factor VIII inhibitor].
Dtsch Med Wochenschr. 1985 May 17;110(20):799-802. doi: 10.1055/s-2008-1068907.
8
Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry.孕期或产后静脉血栓栓塞:来自RIETE注册研究的结果
Thromb Haemost. 2007 Feb;97(2):186-90.
9
Estimates of risk of venous thrombosis during pregnancy and puerperium are not influenced by diagnostic suspicion and referral basis.
Am J Obstet Gynecol. 2004 Sep;191(3):825-9. doi: 10.1016/j.ajog.2004.02.004.
10
Thrombosis associated with the use of recombinant activated factor VII: profiling two events.
Thromb Haemost. 2004 Dec;92(6):1448-9.

引用本文的文献

1
Symptomatic haemophilia A: management during pregnancy and the postpartum period.症状性血友病 A:妊娠及产后期间的管理。
BMJ Case Rep. 2022 Jan 7;15(1):e245474. doi: 10.1136/bcr-2021-245474.
2
Delivery and neuraxial technique outcomes in patients with hemophilia and in hemophilia carriers: a systematic review.血友病患者和携带者的分娩及椎管内技术结局:系统评价。
J Anesth. 2021 Apr;35(2):288-302. doi: 10.1007/s00540-021-02911-1. Epub 2021 Mar 8.
3
Desmopressin treatment combined with clotting factor VIII concentrates in patients with non-severe haemophilia A: protocol for a multicentre single-armed trial, the DAVID study.
去氨加压素治疗联合凝血因子 VIII 浓缩物治疗非重型血友病 A 患者:多中心单臂试验 DAVID 研究方案。
BMJ Open. 2019 Apr 23;9(4):e022719. doi: 10.1136/bmjopen-2018-022719.